title: Considerations for the Utility of the CPIC Guideline for CYP2D6 Genotype and Codeine Therapy.
authors.affiliation: Department of Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis, TN kristine.crews@stjude.org.
authors.forename: Kristine R
authors.initials: KR
authors.lastname: Crews
authors.affiliation: Department of Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis, TN.
authors.forename: Kelly E
authors.initials: KE
authors.lastname: Caudle
authors.affiliation: Center for Molecular Medicine NorthShore University Health System Evanston, IL.
authors.forename: Henry M
authors.initials: HM
authors.lastname: Dunnenberger
authors.affiliation: Department of Pediatrics and Department of Anesthesia Cincinnati Children's Hospital Medical Center Cincinnati, OH.
authors.forename: Senthilkumar
authors.initials: S
authors.lastname: Sadhasivam
authors.affiliation: Division of Clinical Pharmacology Department of Medicine Indiana University School of Medicine Indianapolis, IN.
authors.forename: Todd C
authors.initials: TC
authors.lastname: Skaar
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D003061:Codeine / Q000627:therapeutic use*; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism*; D006801:Humans; D010146:Pain / Q000188:drug therapy*
chemical_list: D000701:Analgesics, Opioid; D019389:Cytochrome P-450 CYP2D6; D003061:Codeine